Article By:
Don Dion
Monday, February 1, 2016 2:52 PM EDT
We remain cautious on the PLx Pharma IPO and suggest investors consider holding off, given the weak IPO market, lack of commercial revenue, and small syndicate.
In this article: PLXP Also: CVS, JNJ, PBH, PFE, WAG (NOW WBA)
